Form 4: Arteris Inc. CEO Charles Janac Reports Stock Transactions

Charles Janac, CEO of Arteris, Inc., reports acquisition of restricted stock units and stock options, as well as gifts of common stock.

Summary

• Charles Janac, the President and CEO of Arteris, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 21, 2025, Janac acquired 68,482 restricted stock units (RSUs) at $0.00, vesting in 16 quarterly installments starting April 1, 2025, bringing his direct holdings to 328,570 shares.
• Also on February 21, 2025, Janac gifted 3,500 shares of common stock at $0.00, reducing his indirect holdings through the Charles and Lydia Janac Trust to 59,752 shares.
• On February 24, 2025, Janac gifted another 3,500 shares of common stock at $0.00, further reducing his indirect holdings through the Charles and Lydia Janac Trust to 56,252 shares.
• Janac also acquired 100,000 stock options with an exercise price of $9.28, vesting in 16 quarterly installments commencing on April 1, 2025, and expiring on February 20, 2035.
• Janac indirectly holds 9,907,691 shares through Bayview Legacy, LLC, where he serves as manager.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document is a standard regulatory filing detailing stock transactions. The acquisition of RSUs and options is mildly positive, suggesting confidence, while the gifting of shares is mildly negative, suggesting slight dilution. Overall, the impact is balanced.

Positives

• The acquisition of RSUs and stock options by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.

Negatives

• The gifting of shares from the Charles and Lydia Janac Trust could be interpreted as a slight dilution of holdings, although the amounts are relatively small compared to overall holdings.

Risks

• The vesting of RSUs and stock options is contingent on continued employment or other conditions, which could be a risk if those conditions are not met.
• Market fluctuations could impact the value of the underlying common stock, affecting the value of the RSUs and stock options.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules of the RSUs and stock options suggest a continued commitment from the CEO to the company's long-term success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of RSUs and stock options is a common form of executive compensation in the tech industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the semiconductor and IP licensing industries, similar to companies like ARM Holdings (now part of SoftBank) and Synopsys.
• The vesting schedules of 16 quarterly installments are also typical, aligning with industry practices for retaining key personnel over a multi-year period.
• The size of the RSU and option grants should be compared to those of peer companies to assess whether the compensation is in line with industry norms.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to potential dilution from the vesting of RSUs and stock options.
• The transactions signal the CEO's continued commitment to the company, which could positively influence employee morale.

Key Dates